141 related articles for article (PubMed ID: 32950597)
21. Low-Cost High-Resolution Microendoscopy for the Detection of Esophageal Squamous Cell Neoplasia: An International Trial.
Protano MA; Xu H; Wang G; Polydorides AD; Dawsey SM; Cui J; Xue L; Zhang F; Quang T; Pierce MC; Shin D; Schwarz RA; Bhutani MS; Lee M; Parikh N; Hur C; Xu W; Moshier E; Godbold J; Mitcham J; Hudson C; Richards-Kortum RR; Anandasabapathy S
Gastroenterology; 2015 Aug; 149(2):321-329. PubMed ID: 25980753
[TBL] [Abstract][Full Text] [Related]
22. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
[TBL] [Abstract][Full Text] [Related]
23. Histopathological evaluation including cytokeratin 13 and Ki-67 in the border between Lugol-stained and -unstained areas.
Ohta K; Ogawa I; Ono S; Taki M; Mizuta K; Miyauchi M; Takechi M; Shigeishi H; Takata T; Kamata N
Oncol Rep; 2010 Jul; 24(1):9-14. PubMed ID: 20514438
[TBL] [Abstract][Full Text] [Related]
24. Durability of radiofrequency ablation for treatment of esophageal squamous cell neoplasia: 5-year follow-up of a treated cohort in China.
Yu X; van Munster SN; Zhang Y; Xue L; Fleischer DE; Weusten BLAM; Lu N; Dawsey SSM; Bergman JJGHM; Wang G
Gastrointest Endosc; 2019 Apr; 89(4):736-748.e2. PubMed ID: 30905354
[TBL] [Abstract][Full Text] [Related]
25. LUGOL'S IODINE CHROMOENDOSCOPY VERSUS NARROW BAND IMAGE ENHANCED ENDOSCOPY FOR THE DETECTION OF ESOPHAGEAL CANCER IN PATIENTS WITH STENOSIS SECONDARY TO CAUSTIC/CORROSIVE AGENT INGESTION.
Pennachi CMPS; Moura DTH; Amorim RBP; Guedes HG; Kumbhari V; Moura EGH
Arq Gastroenterol; 2017; 54(3):250-254. PubMed ID: 28492712
[TBL] [Abstract][Full Text] [Related]
26. Absence of Lugol staining indicates initiation of esophageal squamous cell carcinoma: A combined genomic and epidemiologic study.
Liu Z; Liu M; Liu Y; Zhou R; Abliz A; Yuan W; Guo C; Zhang L; He W; Zheng H; Huang Y; Pan Y; Liu F; Hu Z; Chen H; Cai H; He Z; Ke Y
Cell Rep Med; 2023 Sep; 4(9):101168. PubMed ID: 37625408
[TBL] [Abstract][Full Text] [Related]
27. The clinicopathologic significance of small areas unstained by Lugol's iodine in the mucosa surrounding resected esophageal carcinoma: an analysis of 147 cases.
Nakanishi Y; Ochiai A; Yoshimura K; Kato H; Shimoda T; Yamaguchi H; Tachimori Y; Watanabe H; Hirohashi S
Cancer; 1998 Apr; 82(8):1454-9. PubMed ID: 9554520
[TBL] [Abstract][Full Text] [Related]
28. Endoscopic screening for esophageal squamous-cell carcinoma in high-risk patients: a prospective study conducted in 62 French endoscopy centers.
Dubuc J; Legoux J-; Winnock M; Seyrig J-; Barbier J-; Barrioz T; Laugier R; Boulay G; Grasset D; Sautereau D; Grigoresco D; Butel J; Scoazec J-; Ponchon T;
Endoscopy; 2006 Jul; 38(7):690-5. PubMed ID: 16874909
[TBL] [Abstract][Full Text] [Related]
29. A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.
Liu M; Liu Z; Cai H; Guo C; Li X; Zhang C; Wang H; Hang D; Liu F; Deng Q; Yang X; Yuan W; Pan Y; Li J; Zhang C; Shen N; He Z; Ke Y
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1538-1546.e7. PubMed ID: 28342951
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic findings corresponding to multiple Lugol-voiding lesions in the esophageal background mucosa.
Matsuno K; Ishihara R; Nakagawa K; Ohmori M; Iwagami H; Inoue S; Iwatsubo T; Nakahira H; Matsuura N; Shichijyo S; Maekawa A; Takashi K; Yamamoto S; Takeuchi Y; Higashino K; Uedo N; Matsunaga T
J Gastroenterol Hepatol; 2019 Feb; 34(2):390-396. PubMed ID: 30101499
[TBL] [Abstract][Full Text] [Related]
31. Lugol dye endoscopy for analysis of esophageal mucosa in achalasia.
Yamamuro EM; Cecconello I; Iriya K; Tomishigue T; Oliveira MA; Pinotti HW
Hepatogastroenterology; 1999; 46(27):1687-91. PubMed ID: 10430322
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
[TBL] [Abstract][Full Text] [Related]
33. Patients With Barrett's Esophagus and Confirmed Persistent Low-Grade Dysplasia Are at Increased Risk for Progression to Neoplasia.
Duits LC; van der Wel MJ; Cotton CC; Phoa KN; Ten Kate FJW; Seldenrijk CA; Offerhaus GJA; Visser M; Meijer SL; Mallant-Hent RC; Krishnadath KK; Pouw RE; Tijssen JGP; Shaheen NJ; Bergman JJGHM
Gastroenterology; 2017 Apr; 152(5):993-1001.e1. PubMed ID: 28012849
[TBL] [Abstract][Full Text] [Related]
34. [Endoscopic screening for upper gastrointestinal second primary malignancies in patients with hypopharyngeal squamous cell carcinoma].
Tian JJ; Xu W; Lyu ZH; Ma JK; Cui P; Sa N; Cao HY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Apr; 53(4):292-295. PubMed ID: 29747255
[No Abstract] [Full Text] [Related]
35. A Five-Parameter Logistic Model to Predict the Possibility of Misdiagnosis for Improving the Specificity of Lugol Chromoendoscopy in the Diagnosis of Esophageal Neoplastic Lesions.
Guo Z; Meng L; Tian S; Chen L; Shi H; Fan M; Lin R
Front Oncol; 2021; 11():763375. PubMed ID: 35047392
[TBL] [Abstract][Full Text] [Related]
36. Esophageal Histological Precursor Lesions and Subsequent 8.5-Year Cancer Risk in a Population-Based Prospective Study in China.
Wei WQ; Hao CQ; Guan CT; Song GH; Wang M; Zhao DL; Li BY; Bai WL; Hou PY; Wang JW; Jin GL; Lei FH; Li XQ; Xue LY; Wang GQ; Abnet CC; Taylor PR; Dawsey SM; Qiao YL
Am J Gastroenterol; 2020 Jul; 115(7):1036-1044. PubMed ID: 32618654
[TBL] [Abstract][Full Text] [Related]
37. [Telomerase activity in esophageal carcinoma and lesions unstained with Lugol's solution].
Yoneyama K; Aoyama N; Koizumi H; Tamai S
Nihon Rinsho; 1998 May; 56(5):1181-5. PubMed ID: 9613118
[TBL] [Abstract][Full Text] [Related]
38. [Distribution of esophageal squamous cell cancer and precursor lesions in high-risk areas, Linzhou in Henan province and Feicheng in Shandong province of China, 2005-2009].
Wang M; Hao C; Zhao D; Li B; Wang J; Lei F; Zhou R; Ma S; Ma Q; Li Y; Feng H; Li X; Wei W
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Aug; 49(8):677-82. PubMed ID: 26733024
[TBL] [Abstract][Full Text] [Related]
39. Chromoendoscopy and magnification endoscopy for diagnosing esophageal cancer and dysplasia.
Connor MJ; Sharma P
Thorac Surg Clin; 2004 Feb; 14(1):87-94. PubMed ID: 15382312
[TBL] [Abstract][Full Text] [Related]
40. [Chromoendoscopy in the diagnosis of precancerous lesions of the esophagus. Our experience].
Cristofaro MG; Cafaro D; Lazzaro F; Onofrio L; Savino N; Macchione B; Mauro P; Musella S
Ann Ital Chir; 2001; 72(4):405-9; discussion 409-11. PubMed ID: 11865692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
